These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38529699)

  • 1. Radiprodil, a selective GluN2B negative allosteric modulator, rescues audiogenic seizures in mice carrying the GluN2A(N615S) mutation.
    Bertocchi I; Cifarelli L; Oberto A; Eva CE; Sprengel R; Mirza NR; Muglia P
    Br J Pharmacol; 2024 Jun; 181(12):1886-1894. PubMed ID: 38529699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GRIN2B gain of function mutations are sensitive to radiprodil, a negative allosteric modulator of GluN2B-containing NMDA receptors.
    Mullier B; Wolff C; Sands ZA; Ghisdal P; Muglia P; Kaminski RM; André VM
    Neuropharmacology; 2017 Sep; 123():322-331. PubMed ID: 28533163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiprodil, a NR2B negative allosteric modulator, from bench to bedside in infantile spasm syndrome.
    Auvin S; Dozières-Puyravel B; Avbersek A; Sciberras D; Collier J; Leclercq K; Mares P; Kaminski RM; Muglia P
    Ann Clin Transl Neurol; 2020 Mar; 7(3):343-352. PubMed ID: 32106360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunities for Precision Treatment of
    Han W; Yuan H; Allen JP; Kim S; Shaulsky GH; Perszyk RE; Traynelis SF; Myers SJ
    J Pharmacol Exp Ther; 2022 Apr; 381(1):54-66. PubMed ID: 35110392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for GRIN2A and GRIN2D-related epileptic encephalopathy.
    Hausman-Kedem M; Menascu S; Greenstein Y; Fattal-Valevski A
    Epilepsy Res; 2020 Jul; 163():106325. PubMed ID: 32289570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voltage-independent GluN2A-type NMDA receptor Ca
    Bertocchi I; Eltokhi A; Rozov A; Chi VN; Jensen V; Bus T; Pawlak V; Serafino M; Sonntag H; Yang B; Burnashev N; Li SB; Obenhaus HA; Both M; Niewoehner B; Single FN; Briese M; Boerner T; Gass P; Rawlins JNP; Köhr G; Bannerman DM; Sprengel R
    Commun Biol; 2021 Jan; 4(1):59. PubMed ID: 33420383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia.
    Gao K; Tankovic A; Zhang Y; Kusumoto H; Zhang J; Chen W; XiangWei W; Shaulsky GH; Hu C; Traynelis SF; Yuan H; Jiang Y
    PLoS One; 2017; 12(2):e0170818. PubMed ID: 28182669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains.
    Swanger SA; Chen W; Wells G; Burger PB; Tankovic A; Bhattacharya S; Strong KL; Hu C; Kusumoto H; Zhang J; Adams DR; Millichap JJ; Petrovski S; Traynelis SF; Yuan H
    Am J Hum Genet; 2016 Dec; 99(6):1261-1280. PubMed ID: 27839871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of GluN2A and GluN2B gain-of-function epilepsy mutations on synaptic currents mediated by diheteromeric and triheteromeric NMDA receptors.
    Chen X; Keramidas A; Harvey RJ; Lynch JW
    Neurobiol Dis; 2020 Jul; 140():104850. PubMed ID: 32247039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of NMDA receptor subunit epsilon 1: effects on audiogenic-like seizures induced by electrical stimulation of the inferior colliculus in mice.
    Sakamoto T; Mishina M; Niki H
    Brain Res Mol Brain Res; 2002 Jun; 102(1-2):113-7. PubMed ID: 12191501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of GluN2A NMDA receptors ameliorates synaptic plasticity deficits in the Fmr1
    Lundbye CJ; Toft AKH; Banke TG
    J Physiol; 2018 Oct; 596(20):5017-5031. PubMed ID: 30132892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders.
    Tang W; Liu D; Traynelis SF; Yuan H
    Neuropharmacology; 2020 Oct; 177():108247. PubMed ID: 32712275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Novel PET Tracer [
    van der Aart J; Yaqub M; Kooijman EJM; Bakker J; Langermans JAM; Schuit RC; Hofman MBM; Christiaans JAM; Lammertsma AA; Windhorst AD; van Berckel BNM
    Mol Imaging Biol; 2019 Aug; 21(4):676-685. PubMed ID: 30306318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Epilepsy-Associated GRIN2A Rare Variant Disrupts CaMKIIα Phosphorylation of GluN2A and NMDA Receptor Trafficking.
    Mota Vieira M; Nguyen TA; Wu K; Badger JD; Collins BM; Anggono V; Lu W; Roche KW
    Cell Rep; 2020 Sep; 32(9):108104. PubMed ID: 32877683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent seizure-related GRIN1 variant: Molecular mechanism and targeted therapy.
    Xu Y; Song R; Chen W; Strong K; Shrey D; Gedela S; Traynelis SF; Zhang G; Yuan H
    Ann Clin Transl Neurol; 2021 Jul; 8(7):1480-1494. PubMed ID: 34227748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GRIN2A-related disorders: genotype and functional consequence predict phenotype.
    Strehlow V; Heyne HO; Vlaskamp DRM; Marwick KFM; Rudolf G; de Bellescize J; Biskup S; Brilstra EH; Brouwer OF; Callenbach PMC; Hentschel J; Hirsch E; Kind PC; Mignot C; Platzer K; Rump P; Skehel PA; Wyllie DJA; Hardingham GE; van Ravenswaaij-Arts CMA; Lesca G; Lemke JR;
    Brain; 2019 Jan; 142(1):80-92. PubMed ID: 30544257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Investigation of a GRIN2A Variant Associated with Rolandic Epilepsy.
    Xu XX; Liu XR; Fan CY; Lai JX; Shi YW; Yang W; Su T; Xu JY; Luo JH; Liao WP
    Neurosci Bull; 2018 Apr; 34(2):237-246. PubMed ID: 28936771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsant effects of structurally diverse GABA(B) positive allosteric modulators in the DBA/2J audiogenic seizure test: Comparison to baclofen and utility as a pharmacodynamic screening model.
    Brown JW; Moeller A; Schmidt M; Turner SC; Nimmrich V; Ma J; Rueter LE; van der Kam E; Zhang M
    Neuropharmacology; 2016 Feb; 101():358-69. PubMed ID: 26471422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel missense mutation in GRIN2A causes a nonepileptic neurodevelopmental disorder.
    Fernández-Marmiesse A; Kusumoto H; Rekarte S; Roca I; Zhang J; Myers SJ; Traynelis SF; Couce ML; Gutierrez-Solana L; Yuan H
    Mov Disord; 2018 Jul; 33(6):992-999. PubMed ID: 29644724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perampanel chronic treatment does not induce tolerance and decreases tolerance to clobazam in genetically epilepsy prone rats.
    Citraro R; De Sarro C; Leo A; Donato di Paola E; Palma E; Russo E; De Sarro G
    Epilepsy Res; 2018 Oct; 146():94-102. PubMed ID: 30092489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.